Sign In
Buy SPXCF
Singapore Exchange Earnings Calls
| Release date | Feb 04, 2026 |
| EPS estimate | $0.264 |
| EPS actual | $0.248 |
| EPS Surprise | -6.17% |
| Revenue estimate | 553.478M |
| Revenue actual | 540.465M |
| Revenue Surprise | -2.35% |
| Release date | Aug 05, 2025 |
| EPS estimate | $0.228 |
| EPS actual | $0.225 |
| EPS Surprise | -1.54% |
| Revenue estimate | 544.712M |
| Revenue actual | 539.559M |
| Revenue Surprise | -0.95% |
| Release date | Feb 05, 2025 |
| EPS estimate | $0.220 |
| EPS actual | $0.232 |
| EPS Surprise | 5.42% |
| Revenue estimate | 496.667M |
| Revenue actual | 499.39M |
| Revenue Surprise | 0.548% |
| Release date | Oct 03, 2024 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
Last 4 Quarters for Singapore Exchange
Below you can see how SPXCF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Oct 03, 2024 |
| Price on release | $8.85 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Sep 27, 2024 | $8.57 |
| Sep 30, 2024 | $8.57 |
| Oct 01, 2024 | $8.70 |
| Oct 02, 2024 | $8.85 |
| Oct 03, 2024 | $8.85 |
| Oct 04, 2024 | $8.90 |
| Oct 07, 2024 | $8.90 |
| Oct 08, 2024 | $8.90 |
| Oct 09, 2024 | $8.55 |
| 4 days before | 3.27% |
| 4 days after | -3.39% |
| On release day | 0.565% |
| Change in period | -0.233% |
| Release date | Feb 05, 2025 |
| Price on release | $9.13 |
| EPS estimate | $0.220 |
| EPS actual | $0.232 |
| EPS surprise | 5.42% |
| Date | Price |
|---|---|
| Jan 30, 2025 | $9.00 |
| Jan 31, 2025 | $9.00 |
| Feb 03, 2025 | $9.00 |
| Feb 04, 2025 | $9.13 |
| Feb 05, 2025 | $9.13 |
| Feb 06, 2025 | $9.39 |
| Feb 07, 2025 | $9.39 |
| Feb 10, 2025 | $9.39 |
| Feb 11, 2025 | $10.45 |
| 4 days before | 1.44% |
| 4 days after | 14.46% |
| On release day | 0.97% |
| Change in period | 16.11% |
| Release date | Aug 05, 2025 |
| Price on release | $12.90 |
| EPS estimate | $0.228 |
| EPS actual | $0.225 |
| EPS surprise | -1.54% |
| Date | Price |
|---|---|
| Jul 30, 2025 | $11.70 |
| Jul 31, 2025 | $12.80 |
| Aug 01, 2025 | $12.80 |
| Aug 04, 2025 | $12.80 |
| Aug 05, 2025 | $12.90 |
| Aug 06, 2025 | $12.90 |
| Aug 07, 2025 | $12.75 |
| Aug 08, 2025 | $11.75 |
| Aug 11, 2025 | $13.00 |
| 4 days before | 10.26% |
| 4 days after | 0.775% |
| On release day | 0% |
| Change in period | 11.11% |
| Release date | Feb 04, 2026 |
| Price on release | $14.02 |
| EPS estimate | $0.264 |
| EPS actual | $0.248 |
| EPS surprise | -6.17% |
| Date | Price |
|---|---|
| Jan 29, 2026 | $13.94 |
| Jan 30, 2026 | $14.85 |
| Feb 02, 2026 | $14.85 |
| Feb 03, 2026 | $14.02 |
| Feb 04, 2026 | $14.02 |
| Feb 05, 2026 | $14.02 |
| Feb 06, 2026 | $14.02 |
| Feb 09, 2026 | $14.69 |
| Feb 10, 2026 | $14.69 |
| 4 days before | 0.574% |
| 4 days after | 4.78% |
| On release day | 0% |
| Change in period | 5.38% |
Singapore Exchange Earnings Call Transcript Summary of Q4 2025
SGX Group reported a record FY2025 with highest-ever revenue and net profit, driven by its multi-asset strategy. Key segment performance: cash equities revenue +19% (SDAV +26.5%), derivatives net revenue +9% (DDAV +17%; T+1 session growth strong), and SGX FX (OTC FX) net revenue +25% (ADV +28% to USD 143bn). Group net revenue rose 11.7% to $1,298m; adjusted NPAT up 15.9% to $610m. Management proposed raising the final quarterly dividend and a phased dividend step-up of $0.0025 per quarter from FY26–FY28; FY25 total dividend $0.375/sh. Medium-term targets include 6–8% revenue CAGR (ex treasury income), FY26 expenses guided to rise 4–6%, CapEx $90–95m (≈7% of operating revenue over a cycle). Balance sheet remains strong (leverage c.0.8x), and SGX is pursuing disciplined capital allocation with scope for bolt-on M&A. IPO pipeline visibility improved (30+ companies). New product initiatives include Brazilian Real futures, Micro FTSE Taiwan futures and work toward a regulated crypto perpetual product (timing around year-end, subject to readiness). Management emphasised continued investment in technology, product shelf expansion (China/India corridors, ETFs, SDRs), and operational resilience to capture sustained capital flows into Asia.
